Zobrazeno 1 - 10
of 18
pro vyhledávání: '"PM Hickey"'
Autor:
Kenneth Monaghan, Patrick Broderick, Frances Horgan, Daniel Simpson, Paula Pm Hickey, Catherine Blake, Monika Ehrensberger, Joanne OʼReilly
Publikováno v:
American journal of physical medicinerehabilitation. 98(8)
Objective The aim of the study was to investigate the feasibility and potential effectiveness of mirror-aided cross-education compared with cross-education alone in poststroke upper limb recovery. Design A pilot randomized controlled parallel group s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3ec16095005a52676dbada79a812290
https://pubmed.ncbi.nlm.nih.gov/31318745
https://pubmed.ncbi.nlm.nih.gov/31318745
Autor:
Stephen Bourke, K Heslop-Marshall, John Steer, Nick Steen, Richard Harrison, PM Hickey, AJ Simpson, SC Stenton, Carlos Echevarria, Rodney Hughes, Meme Wijesinghe, Grant Gibson
Publikováno v:
Thorax
Background\ud Hospitalisation due to acute\ud exacerbations of COPD (AECOPD) is common, and\ud subsequent mortality high. The DECAF score was derived\ud for accurate prediction of mortality and risk strati\ud fi\ud cation\ud to inform patient care. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72f1ed47837515f1398462a646c8a8b3
http://europepmc.org/articles/PMC4752621
http://europepmc.org/articles/PMC4752621
Autor:
Richard Harrison, Carlos Echevarria, AJ Simpson, SC Stenton, Rodney Hughes, PM Hickey, John Steer, Stephen Bourke, Nick Steen, Grant Gibson, Meme Wijesinghe, Karen Heslop-Marshall
Publikováno v:
Thorax. 72(8)
Background One in three patients hospitalised due to acute exacerbation of COPD (AECOPD) is readmitted within 90 days. No tool has been developed specifically in this population to predict readmission or death. Clinicians are unable to identify patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5263344ea3b27ed6be394011296287ad
https://pubmed.ncbi.nlm.nih.gov/28465408
https://pubmed.ncbi.nlm.nih.gov/28465408
Autor:
Kenneth Monaghan, Frances Horgan, Catherine Cornall, Bernadette E Lyons, Catherine Blake, Peter Langhorne, Paula Pm Hickey
Publikováno v:
The Cochrane Library
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: PRIMARY: To determine if physical treatment interventions are effective in preventing or minimising activity limitation and participation restrictions in those pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::019fc1abc5c0f1a39236a19950b54f0d
https://doi.org/10.1002/14651858.cd009188
https://doi.org/10.1002/14651858.cd009188
Autor:
Meme Wijesinghe, Karen Heslop-Marshall, Stephen Bourke, Richard Harrison, PM Hickey, SC Stenton, John Steer, Rodney Hughes, Carlos Echevarria, Grant Gibson, AJ Simpson, Nick Steen
Publikováno v:
Thorax. 70:A35-A35
Background Exacerbation of COPD is the second commonest reason for hospital admission, with high subsequent readmission and mortality rates among those who survive to discharge. Risk stratification would inform efficient use of services. Methods Cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35114e2ad8342eaee8a0e7623bccb70e
https://doi.org/10.1136/thoraxjnl-2015-207770.64
https://doi.org/10.1136/thoraxjnl-2015-207770.64
Autor:
Hickey PM; Department of Psychology, University of New Brunswick Saint John, Saint John, New Brunswick, Canada., Best LA; Department of Psychology, University of New Brunswick Saint John, Saint John, New Brunswick, Canada., Speed D; Department of Psychology, University of New Brunswick Saint John, Saint John, New Brunswick, Canada.
Publikováno v:
Journal of homosexuality [J Homosex] 2024 Dec 05; Vol. 71 (14), pp. 3276-3294. Date of Electronic Publication: 2023 Nov 29.
Autor:
Lewis RA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Johns CS; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Cogliano M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Capener D; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Tubman E; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Sabroe I; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Thompson AAR; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Billings CG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Hamilton N; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Baster K; Statistical Services Unit, School of Mathematics and Statistics and., Laud PJ; Statistical Services Unit, School of Mathematics and Statistics and., Hickey PM; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Middleton J; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Armstrong IJ; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Hurdman JA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Lawrie A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Rothman AMK; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Feb 15; Vol. 201 (4), pp. 458-468.
Autor:
Sweatt AJ; From the Division of Pulmonary and Critical Care Medicine (A.J.S., M.R.N., R.T.Z.), in the Department of Medicine, Stanford University, CA.; Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, CA (A.J.S., A.H., M.R.N., M.R., R.T.Z.)., Hedlin HK; Quantitative Sciences Unit (H.K.H., V.B.), in the Department of Medicine, Stanford University, CA., Balasubramanian V; Quantitative Sciences Unit (H.K.H., V.B.), in the Department of Medicine, Stanford University, CA., Hsi A; Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, CA (A.J.S., A.H., M.R.N., M.R., R.T.Z.)., Blum LK; Division of Immunology and Rheumatology (L.K.B., W.H.R.), in the Department of Medicine, Stanford University, CA., Robinson WH; Division of Immunology and Rheumatology (L.K.B., W.H.R.), in the Department of Medicine, Stanford University, CA., Haddad F; Division of Cardiovascular Medicine (F.H.), in the Department of Medicine, Stanford University, CA.; Stanford Cardiovascular Institute (F.H.), in the Department of Medicine, Stanford University, CA., Hickey PM; Department of Infection, Immunity, and Cardiovascular Disease, University of Sheffield, United Kingdom (P.M.H., A.L.)., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, United Kingdom (R.C.)., Lawrie A; Department of Infection, Immunity, and Cardiovascular Disease, University of Sheffield, United Kingdom (P.M.H., A.L.)., Nicolls MR; From the Division of Pulmonary and Critical Care Medicine (A.J.S., M.R.N., R.T.Z.), in the Department of Medicine, Stanford University, CA.; Institute for Immunity, Transplantation, and Infection (M.R.N., P.K.), in the Department of Medicine, Stanford University, CA.; Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, CA (A.J.S., A.H., M.R.N., M.R., R.T.Z.)., Rabinovitch M; Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, CA (A.J.S., A.H., M.R.N., M.R., R.T.Z.).; Department of Pediatric Cardiology, Stanford University, CA (M.R.)., Khatri P; Institute for Immunity, Transplantation, and Infection (M.R.N., P.K.), in the Department of Medicine, Stanford University, CA.; Division of Biomedical Informatics Research (P.K.) in the Department of Medicine, Stanford University, CA., Zamanian RT; From the Division of Pulmonary and Critical Care Medicine (A.J.S., M.R.N., R.T.Z.), in the Department of Medicine, Stanford University, CA.; Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, CA (A.J.S., A.H., M.R.N., M.R., R.T.Z.).
Publikováno v:
Circulation research [Circ Res] 2019 Mar 15; Vol. 124 (6), pp. 904-919.
Autor:
Hickey PM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Pulmonary Vascular Diseases Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom., Lawrie A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Condliffe R; Pulmonary Vascular Diseases Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2018 Jun 06; Vol. 5, pp. 175. Date of Electronic Publication: 2018 Jun 06 (Print Publication: 2018).
Autor:
Pickworth J; 1 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., Rothman A; 1 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., Iremonger J; 1 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., Casbolt H; 1 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., Hopkinson K; 1 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., Hickey PM; 1 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., Gladson S; 2 Vanderbilt Institute, Nashville, TN, USA., Shay S; 2 Vanderbilt Institute, Nashville, TN, USA., Morrell NW; 3 Department of Medicine, University of Cambridge, Cambridge, UK., Francis SE; 1 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., West JD; 2 Vanderbilt Institute, Nashville, TN, USA., Lawrie A; 1 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Publikováno v:
Pulmonary circulation [Pulm Circ] 2017 Oct-Dec; Vol. 7 (4), pp. 768-776. Date of Electronic Publication: 2017 Sep 22.